The precarious climate in the US might have spooked some pharma investors – but others are looking to targeted therapies to get more bang for their buck.

Data generating devices may seem gimmicky, but they are poised to transform healthcare

Patient recruitment for clinical trials is commonly accepted to be a herculean task. A new platform could make the process a lot quicker and easier – and, crucially, not at the expense of data privacy

AstraZeneca's Head of Real World Evidence shares the story behind AZ's seminal RWE study and casts his projections on the future